SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter.
The San Diego-based company said it had a loss of 18 cents per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
For the year, the company reported that its loss widened to $64 million, or 86 cents per share. Revenue was reported as $235,000.
In the final minutes of trading on Thursday, the company’s shares hit $3.98. A year ago, they were trading at $1.63.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATYR at https://www.zacks.com/ap/ATYR
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
